Stay updated on Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a minor site revision note: 'Revision: v3.3.2' replacing the previous 'Revision: v3.3.1' on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:41:16.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Page footer revision updated from v3.2.0 to v3.3.1. The study content and user-facing functionality remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-24T14:39:46.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice about NIH operating status from the page; this is a non-critical notice and does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:48:39.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; core study details, eligibility criteria, and locations appear unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T01:14:17.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.
    Difference
    4%
    Check dated 2025-10-05T10:23:37.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.5%
    Check dated 2025-09-28T03:18:55.000Z thumbnail image

Stay in the know with updates to Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Anti-IL5 Inadequate Responders Clinical Trial page.